ID: ALA4129427

Max Phase: Preclinical

Molecular Formula: C7H12ClN3S

Molecular Weight: 169.25

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cl.N=C(N)NCCc1cccs1

Standard InChI:  InChI=1S/C7H11N3S.ClH/c8-7(9)10-4-3-6-2-1-5-11-6;/h1-2,5H,3-4H2,(H4,8,9,10);1H

Standard InChI Key:  LDUPUFQGZBXJRB-UHFFFAOYSA-N

Associated Targets(Human)

Adrenergic receptor alpha-2 812 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 169.25Molecular Weight (Monoisotopic): 169.0674AlogP: 0.77#Rotatable Bonds: 3
Polar Surface Area: 61.90Molecular Species: BASEHBA: 2HBD: 3
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 12.44CX LogP: 0.97CX LogD: -1.45
Aromatic Rings: 1Heavy Atoms: 11QED Weighted: 0.46Np Likeness Score: -1.76

References

1. Flood A, Trujillo C, Sanchez-Sanz G, Kelly B, Muguruza C, Callado LF, Rozas I..  (2017)  Thiophene/thiazole-benzene replacement on guanidine derivatives targeting α2-Adrenoceptors.,  138  [PMID:28644987] [10.1016/j.ejmech.2017.06.008]

Source